Literature DB >> 23439101

UNITAID can address HCV/HIV co-infection.

Tido von Schoen-Angerer, Jennifer Cohn, Tracy Swan, Peter Piot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23439101     DOI： 10.1016/S0140-6736(13)60346-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  A treatment revolution for those who can afford it? Hepatitis C treatment: new medications, profits and patients.

Authors:  Maria Phelan; Catherine Cook
Journal:  BMC Infect Dis       Date:  2014-09-19       Impact factor: 3.090

Review 2.  Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to date.

Authors:  José Fernando Vilela-Martin
Journal:  Drug Des Devel Ther       Date:  2016-05-09       Impact factor: 4.162

Review 3.  Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C.

Authors:  Allison M Bell; Jamie L Wagner; Katie E Barber; Kayla R Stover
Journal:  Int J Hepatol       Date:  2016-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.